SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotime-Nasdaq's best kept secret?
BTIM 0.00010000.0%Nov 5 1:26 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jim Roof who wrote (830)4/12/1998 6:00:00 PM
From: Stephen How   of 1432
 
I found some data on the annual U.S. hetastarch usage while reading about coagulopathy.

I interpreted a US hetastarch sales figure of $50M/year based on a $46/liter cost from [1]. I didn't do any calculation, but just translated from their context of a savings calculation of hetastarch relative to albumin.

[1] Warren BB, Durieux ME. Hydroxyethl starch: safe or not? Anesth Analg 1997; 84: 206-12.

Steve
btim.dyn.ml.org
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext